(NDAQ) Nasdaq - Ratings and Ratios
Indices, Surveillance, Verafin, AxiomSL, Calypso
NDAQ EPS (Earnings per Share)
NDAQ Revenue
Description: NDAQ Nasdaq September 26, 2025
Nasdaq, Inc. (NASDAQ:NDAQ) is a technology-focused provider to capital markets and adjacent industries, organized into three operating segments: Capital Access Platforms, Financial Technology, and Market Services. The firm distributes both historical and real-time market data, licenses Nasdaq-branded indices, and offers a suite of governance, sustainability, and investor-relations solutions. It also runs a portfolio of software platforms-including Verafin (AML/fraud detection), AxiomSL (regulatory reporting), Calypso (cross-asset trading and risk), and a surveillance SaaS-to support compliance, risk management, and trade workflow for exchanges, clearing houses, and institutional participants.
According to Nasdaq’s FY 2023 Form 10-K, total revenue reached approximately **$6.2 billion**, with the Data Services line (historical/real-time market data) contributing roughly **45 %** of that total and delivering an operating margin near **30 %**. The company reported diluted earnings per share of **$2.30**, and its cash-equity and derivatives trading volumes grew **~7 % YoY**, reflecting continued demand for electronic execution and post-trade services. A key sector driver is the accelerating shift toward algorithmic and high-frequency trading, which boosts the premium placed on low-latency data feeds and real-time analytics.
Nasdaq’s growth outlook is contingent on several uncertain factors: (1) **Trading volume volatility**-revenues from exchange and clearing services are highly correlated with global equity and derivatives turnover, which can swing with macro-economic cycles; (2) **Regulatory evolution**-new reporting or surveillance mandates could expand demand for Nasdaq’s SaaS solutions but also raise compliance costs; and (3) **Competitive pressure** from rivals such as Intercontinental Exchange (ICE) and CME Group, which may erode market-share if they launch more integrated data-plus-execution bundles. The recent acquisition of Verafin (2020) has begun to diversify revenue, yet its contribution to total earnings remains modest (<5 % of FY 2023 revenue), so the extent of future cross-selling opportunities is still uncertain.
If you’re interested in a deeper quantitative comparison of Nasdaq’s valuation metrics versus peers, a quick look at **ValueRay** can surface the most recent analyst consensus, forward-looking cash-flow estimates, and scenario-based risk assessments.
NDAQ Stock Overview
| Market Cap in USD | 49,031m |
| Sub-Industry | Financial Exchanges & Data |
| IPO / Inception | 2002-07-01 |
NDAQ Stock Ratings
| Growth Rating | 58.4% |
| Fundamental | 73.1% |
| Dividend Rating | 62.1% |
| Return 12m vs S&P 500 | -2.04% |
| Analyst Rating | 3.95 of 5 |
NDAQ Dividends
| Dividend Yield 12m | 1.19% |
| Yield on Cost 5y | 2.53% |
| Annual Growth 5y | 9.79% |
| Payout Consistency | 98.3% |
| Payout Ratio | 31.1% |
NDAQ Growth Ratios
| Growth Correlation 3m | -85.1% |
| Growth Correlation 12m | 72.1% |
| Growth Correlation 5y | 67.5% |
| CAGR 5y | 10.86% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.35 |
| CAGR/Mean DD 3y (Pain Ratio) | 0.96 |
| Sharpe Ratio 12m | 2.36 |
| Alpha | -2.89 |
| Beta | 1.030 |
| Volatility | 20.90% |
| Current Volume | 2770.3k |
| Average Volume 20d | 2770.3k |
| Stop Loss | 83.6 (-3%) |
| Signal | 0.18 |
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (1.62b TTM) > 0 and > 6% of Revenue (6% = 490.1m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA 2.06pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -1.32% (prev -5.35%; Δ 4.02pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 2.33b > Net Income 1.62b (YES >=105%, WARN >=100%) |
| Net Debt (8.86b) to EBITDA (2.98b) ratio: 2.97 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.99 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (579.0m) change vs 12m ago -0.00% (target <= -2.0% for YES) |
| Gross Margin 49.72% (prev 41.61%; Δ 8.11pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 26.69% (prev 22.95%; Δ 3.73pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 8.38 (EBITDA TTM 2.98b / Interest Expense TTM 281.0m) >= 6 (WARN >= 3) |
Altman Z'' 1.89
| (A) -0.00 = (Total Current Assets 7.60b - Total Current Liabilities 7.71b) / Total Assets 30.65b |
| (B) 0.30 = Retained Earnings (Balance) 9.22b / Total Assets 30.65b |
| (C) 0.08 = EBIT TTM 2.36b / Avg Total Assets 30.61b |
| (D) 0.40 = Book Value of Equity 7.38b / Total Liabilities 18.62b |
| Total Rating: 1.89 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 73.12
| 1. Piotroski 6.50pt = 1.50 |
| 2. FCF Yield 3.62% = 1.81 |
| 3. FCF Margin 25.69% = 6.42 |
| 4. Debt/Equity 0.79 = 2.19 |
| 5. Debt/Ebitda 2.97 = -1.73 |
| 6. ROIC - WACC (= 0.70)% = 0.88 |
| 7. RoE 13.96% = 1.16 |
| 8. Rev. Trend 90.07% = 6.76 |
| 9. EPS Trend 82.52% = 4.13 |
What is the price of NDAQ shares?
Over the past week, the price has changed by +0.62%, over one month by -2.25%, over three months by -10.49% and over the past year by +12.45%.
Is Nasdaq a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of NDAQ is around 79.15 USD . This means that NDAQ is currently overvalued and has a potential downside of -8.17%.
Is NDAQ a buy, sell or hold?
- Strong Buy: 6
- Buy: 7
- Hold: 5
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the NDAQ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 102.7 | 19.1% |
| Analysts Target Price | 102.7 | 19.1% |
| ValueRay Target Price | 88 | 2.1% |
NDAQ Fundamental Data Overview November 06, 2025
P/E Trailing = 30.6679
P/E Forward = 23.9234
P/S = 6.0029
P/B = 4.2431
P/EG = 1.3912
Beta = 1.03
Revenue TTM = 8.17b USD
EBIT TTM = 2.36b USD
EBITDA TTM = 2.98b USD
Long Term Debt = 9.08b USD (from longTermDebt, last fiscal year)
Short Term Debt = 431.0m USD (from shortTermDebt, last quarter)
Debt = 9.55b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.86b USD (from netDebt column, last quarter)
Enterprise Value = 57.89b USD (49.03b + Debt 9.55b - CCE 697.0m)
Interest Coverage Ratio = 8.38 (Ebit TTM 2.36b / Interest Expense TTM 281.0m)
FCF Yield = 3.62% (FCF TTM 2.10b / Enterprise Value 57.89b)
FCF Margin = 25.69% (FCF TTM 2.10b / Revenue TTM 8.17b)
Net Margin = 19.89% (Net Income TTM 1.62b / Revenue TTM 8.17b)
Gross Margin = 49.72% ((Revenue TTM 8.17b - Cost of Revenue TTM 4.11b) / Revenue TTM)
Gross Margin QoQ = 80.34% (prev 41.20%)
Tobins Q-Ratio = 1.89 (Enterprise Value 57.89b / Total Assets 30.65b)
Interest Expense / Debt = 0.96% (Interest Expense 92.0m / Debt 9.55b)
Taxrate = 20.04% (106.0m / 529.0m)
NOPAT = 1.88b (EBIT 2.36b * (1 - 20.04%))
Current Ratio = 0.99 (Total Current Assets 7.60b / Total Current Liabilities 7.71b)
Debt / Equity = 0.79 (Debt 9.55b / totalStockholderEquity, last quarter 12.02b)
Debt / EBITDA = 2.97 (Net Debt 8.86b / EBITDA 2.98b)
Debt / FCF = 4.22 (Net Debt 8.86b / FCF TTM 2.10b)
Total Stockholder Equity = 11.64b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.30% (Net Income 1.62b / Total Assets 30.65b)
RoE = 13.96% (Net Income TTM 1.62b / Total Stockholder Equity 11.64b)
RoCE = 11.37% (EBIT 2.36b / Capital Employed (Equity 11.64b + L.T.Debt 9.08b))
RoIC = 9.04% (NOPAT 1.88b / Invested Capital 20.84b)
WACC = 8.34% (E(49.03b)/V(58.58b) * Re(9.81%) + D(9.55b)/V(58.58b) * Rd(0.96%) * (1-Tc(0.20)))
Discount Rate = 9.81% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 2.55%
[DCF Debug] Terminal Value 73.90% ; FCFE base≈1.84b ; Y1≈2.05b ; Y5≈2.70b
Fair Price DCF = 60.67 (DCF Value 34.64b / Shares Outstanding 571.0m; 5y FCF grow 13.13% → 3.0% )
EPS Correlation: 82.52 | EPS CAGR: 12.28% | SUE: 2.09 | # QB: 2
Revenue Correlation: 90.07 | Revenue CAGR: 8.06% | SUE: 0.78 | # QB: 0
Additional Sources for NDAQ Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle